14 / 15
Page 36
allied
academies
August 23-24, 2018 | London, UK
Hematology and Oncology
2
nd
International Conference on
Journal of Hematology and Blood Disorder | Volume 2
Diffuse Large B Cell Lymphoma and Clinical Intervention
Ashok Srivastava
Clinfomatrix Oncology, USA
D
iffuse large B-cell lymphoma: It is themost common type of
non-Hodgkin lymphoma among adults. Diffuse large B-cell
lymphoma occurs primarily in older individuals, with a median
age of diagnosis at approximately 65-70 years of age, though it
can also occur in children and young adults in rare cases. Diffuse
large B-cell lymphoma is an aggressive tumor, sometimes
associated with fever, weight loss, and night sweats. The
cause of diffuse large B-cell lymphoma is not well understood.
Typically, diffuse large B-cell lymphoma arises from normal
B cells, but it can also represent a malignant transformation
of other types of lymphoma or leukemia. However, the usual
treatment of these is chemotherapy, often in combination with
anantibody targetedat the tumor cells. However, survival rateof
patients varies. The details of the clinical data will be presented.
e:
ashok.srivastava@curepharmaceuticaslinc.com